Postbiotic publications

Driving new research

Scientific research is key to our product offerings. We have over 20 years of experience in performing clinical trials and post-marketing studies, engaging in international, multidisciplinary collaborations across the globe to help build knowledge around our product concepts. Explore publications that support postbiotics below.

Effectiveness and Safety of Lactobacillus LB in the Treatment of Mild Acute Diarrhea in Children

Eduardo Salazar-Lindo, Dante Figueroa-Quintanilla, Maria Isabel Caciano, Victoria Reto-Valiente, Gilles Chauviere, Patrick Colin
J Pediatr Gastroenterol Nutr. 2007 May;44(5): 571-6

An experimental study and a randomized, double-blind, placebo-controlled clinical trial to evaluate the antisecretory activity of Lactobacillus acidophilus strain LB against nonrotavirus diarrhea

Vanessa Liévin-Le Moal, Luis E Sarrazin-Davila, Alain L Servin
Pediatrics, 2007 Oct;120(4): e795-803

Multicenter, randomized, controlled trial of heat-killed Lactobacillus acidophilus LB in patients with chronic diarrhea

Shu-Dong Xiao, De Zhong Zhang, Hong Lu, Shi Hu Jiang, Hou Yu Liu, Geng Sheng Wang, Guo Ming Xu, Zhong Bing Zhang, Geng Jin Lin, Guo Liang Wang
Adv Ther. 2003 Sep-Oct;20(5): 253-60

The effect of inactivated Lactobacillus LB fermented culture medium on symptom severity: observational investigation in 297 patients with diarrhea-predominant irritable bowel syndrome

A L Tarrerias, V Costil, F Vicari, J C Létard, P Adenis-Lamarre, A Aisène, D Batistelli, G Bonnaud, S Carpentier, P Dalbiès, S Ecuer, J Etienne, M Fantoli, B Grunberg, P Lannoy, J Lapuelle, A Margulies, M Neumeier, J M Rouillon, L Schmets, M P Pingannaud, P Coulom, F Kholer, J M Canard
Dig Dis. 2011;29(6): 588-91, doi: 10.1159/000332987

Clinical evaluation of the addition of lyophilized, heat-killed Lactobacillus acidophilus LB to oral rehydration therapy in the treatment of acute diarrhea in children

N Simakachorn, V Pichaipat, P Rithipornpaisarn, C Kongkaew, P Tongpradit, W Varavithya
J Pediatr Gastroenterol Nutr. 2000 Jan;30(1): 68-72

Treatment of irritable bowel syndrome with Lacteol Fort: a randomized, double-blind, cross-over trial

G M Halpern, T Prindiville, M Blankenburg, T Hsia, M E Gershwin
Am J Gastroenterol, 1996 Aug;91(8): 1579-85

Related articles
  • What does the latest gut health research tell us about Humiome® B2’s potential for a healthy gut microbiome? Ask the scientist

    What does the latest gut health research tell us about Humiome® B2’s potential for a healthy gut microbiome? Ask the scientist

    Discover the latest gut health research showing how Humiome® B2 is driving Health from the Gut innovation.

  • How can prebiotic ingredients provide holistic health benefits through the gut microbiome?

    How can prebiotic ingredients provide holistic health benefits through the gut microbiome?

    Discover emerging research on the benefits of prebiotic ingredients beyond digestive health and opportunities for innovation in holistic health from the gut.

  • It takes guts and science: Unlock the latest research behind human milk oligosaccharides (HMOs) for human health

    It takes guts and science: Unlock the latest research behind human milk oligosaccharides (HMOs) for human health

    Discover new science behind human milk oligosaccharides in gut health and immunity to guide your next supplement development.

How can we help you?

  • New product concept

    Got a notion for your next project or breakthrough innovation? Let’s put our heads together.

  • Sample request

    Don’t just take our word for it. Discover how our solutions can support your product development journey. 

  • Quote request

    Tell us about your project needs. We’ll build you a tailored quote.